Dextra Laboratories Ltd (Dextra) provides synthesis, analysis and manufacture of carbohydrates services to pharmaceutical and biotechnology companies. The product portfolio of the company includes oligosaccharides, glycoconjugates, N-glycans and imino sugars. It offers route design, process development, optimization and scale-up, process validation, effective multi-step synthesis and technology transfer charide and chiral chemistry. In addition Dextra provides custom manufacturing of API and APIs (with DMFs) with specialization in carbohydrate and bile acid derivatives; pre-clinical and clinical materials, including process design and optimization with proper documentation. The company focuses on construction of new GMP laboratories to enable programmes through discovery to early phase clinical trials supply. Dextra is headquartered in Reading, the UK.